CVRx | Barostim
Avatar

Patient Selection and Real World Experience

By CVRx | Barostim FEATURING Christina Economides
By CVRx | Barostim FEATURING Christina Economides
1,191 views
August 10, 2022

Dr. Economides reviews patient identification and case experience with Barostim.

0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
18:36
CVRx | Barostim

Barostim and the Window of Opportunity in Class II/III HFrEF Patient…

Feat. W. Abraham, G. Panjrath, D. Yaranov, P. Mccann
09:58
CVRx | Barostim

Barostim for HFrEF Patients

Feat. P. Mccann
10:18
CVRx | Barostim

New Insights from the BeAT-HF Clinical Study

Feat. W. Abraham
06:16
CVRx | Barostim

Challenges and Opportunities with Contemporary GDMT

Feat. D. Yaranov
12:16
CVRx | Barostim

HFSA 2023: Window of Opportunity – Who and When

Feat. G. Panjrath
16:32
CVRx | Barostim

ESC 2023: BeAT-HF: Long term outcome

Feat. M. Zile
11:49
CVRx | Barostim

ESC 2023: Unmet needs and opportunities with device therapies of HFr…

Feat. W. Abraham
11:43
CVRx | Barostim

ESC 2023: Real-world experience with Baroreflex Activation Therapy

Feat. F. Arribas
06:23
CVRx | Barostim

ESC 2023: Baroreflex Activation Therapy for HFrEF Patients: Long-Ter…

Feat. W. Abraham, F. Arribas, M. Zile
16:00
CVRx | Barostim

HFA 2023: BeAT-HF: Long-Term Safety Profile and Outcomes

Feat. F. Zannad
12:14
CVRx | Barostim

HFA 2023: Challenges and Unmet Needs in GDMT for HFrEF

Feat. J. Lindenfeld
07:42
CVRx | Barostim

HFA 2023: Autonomic Dysfunction in HFrEF

Feat. M. Fudim
18:26
CVRx | Barostim

HFA 2023: Unlocking the Potential of Baroreflex Activation in Heart …

Feat. F. Zannad, J. Lindenfeld, M. Fudim
10:51
CVRx | Barostim

VAM 2023: Baroreflex Activation Therapy - A Novel Extravascular Proc…

Feat. M. PEREZ-IZQUIERDO
07:52
CVRx | Barostim

VAM 2023: Baroreflex Activation Therapy - A Novel Extravascular Proc…

Feat. C. Darling
06:59
CVRx | Barostim

VAM 2023: Baroreflex Activation Therapy - A Novel Extravascular Proc…

Feat. C. Darling, M. PEREZ-IZQUIERDO
10:51
CVRx | Barostim

Our Experience with Barostim in over 40 Patients to Date

Feat. P. Mccann
14:36
CVRx | Barostim

Barostim in the EP's HFrEF Toolbox

Feat. R. Alimohammad
09:39
CVRx | Barostim

Unmet Needs and Device Therapies in HFrEF

Feat. J. Singh
17:44
Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

18:34
Houston Methodist DeBakey Heart and Vascular Center

ECG Interpretation: Everything You Need to Know to Understand and In…

Feat. A. Dave
20:59
Mary E. Money

Digoxin Update 2023: Are the Current Digoxin Monitoring Guidelines H…

37:36
Michigan Medicine

Implementation of Drug Therapies for Heart Failure with Reduced Ejec…

Feat. J. Golbus
16:48
Vaishnavi Kundel

ATS 2023 Insights: To PAP or Not to PAP - Heart Failure and Sleep Di…

Feat. V. Kundel
26:02
Mayo Clinic Pulmonary and Critical Care Educational Series

Right Heart Failure Secondary to Non-Group 1 PH

Feat. H. Cajigas
24:57
24th Annual Heart Failure 2020: an Update on Therapy

50th Anniversary of the Swan-Ganz Catheter: Development of the Swan-…

Feat. J. Forrester
16:00
24th Annual Heart Failure 2020: an Update on Therapy

COVID-19 and Heart Failure

Feat. M. Mehra
09:00
Cecilia Bahit

The Best of AHA23 for the Primary Care Doctor

60:13
CVRx | Barostim

Baroreflex Activation Therapy: A Novel Approach for HFrEF Patients

Feat. G. Panjrath, C. Economides, J. Jefferies
21:39
24th Annual Heart Failure 2020: an Update on Therapy

Myocarditis and Heart Failure: Diagnosis, Prognosis and Treatment

Feat. L. Cooper
15:16
24th Annual Heart Failure 2020: an Update on Therapy

Current Status of Endomyocardial Biopsy

Feat. L. Cooper
27:02
16th Annual Mid-Atlantic Hospital Medicine Symposium

Acute Heart Failure and Knowing Medications

Feat. A. Lala-Trindade
35:15
NYU Langone

Amyloidosis, Other Infiltrative Heart Disease, and What You Need to …

Feat. A. Reyentovich
09:32
CVRx | Barostim

The Baroreflex as a Therapeutic Target in HFrEF

Feat. G. Panjrath
25:05
Heart, Diabetes and Kidney: Make the Link

Heart Failure, the Picture is Changing: Q&A Discussion

Feat. P. Seferovic, E. Standl, M. Ibrahim
11:17
Basem Mishriky

ADA 2022: Heart Failure Hospitalization Among Non-Hispanic Black Com…

05:21
Cardiometabolic Health Congress (CMHC)

2020 CMHC Update on Hyperkalemia in Cardiometabolic Patients: What A…

Feat. I. Pina
33:44
Scripps Health

New Therapies for Pulmonary Venous Hypertension: Updates on the Trea…

Feat. R. C. Mohan
35:30
NYU Langone

Cardiology for the Generalist - Assessment and Management of Heart F…

Feat. A. Reyentovich